FDA proposes ban on bulk compounding of semaglutide and tirzepatide

The FDA has proposed excluding weight-loss drugs, such as Ozempic/Wegovy and Zepbound from a key compounding list, potentially ‌limiting large-scale production by outsourcing facilities.
 
MEDICALNEWSTODAY | DAILY NEWS
 
 
FDA proposes ban on bulk compounding of semaglutide and tirzepatide
 
READ ON
→
What to know about cholecystitis
 
READ ON
→
Tips to strengthen the immune system
 
READ ON
→
 
 
 
 
 
How can you reduce facial swelling?
 
 
ADHD: Why do women get missed out?
 
LISTEN ON Spotify   Listen on Apple Podcasts  
 
 
 
 
 
 
 
 
 
 
 
 
MNT
 
fb   tw   insta
 
 

Comments

Popular posts from this blog

Gaa Chuye Bolo Lyrics (গা ছুঁয়ে বলো) Tanjib Sarowar | Abanti Sithi

Srotoshini Lyrics (স্রোতস্বিনী) Encore Band

Beyond the Data From Drew Altman:  Forward or Backward on the Uninsured?